세계의 기계식 인공호흡기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 환기 모드별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Mechanical Ventilator Market Size, Share & Trends Analysis Report By Product (Critical Care, Neonatal, Transport & Portable), By Ventilation Mode (Invasive, Non-invasive), By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

기계식 인공호흡기 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 기계식 인공호흡기 시장 규모는 2030년까지 42억 2,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 4.90%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

코로나19의 전례 없는 여명, 만성폐쇄성폐질환(COPD) 발병률 증가, 호흡기 응급질환 발병률 증가, 호흡보호장비의 기술 혁신이 기계식 인공호흡기 시장을 견인하는 주요 요인입니다.

기도 양압(PAP) 장치 부문의 급속한 기술 혁신, 휴대성, 운반 및 휴대용 장치의 배터리 수명 향상과 같은 기술 발전은 기계식 인공호흡기 사용을 촉진하는 주요 요인으로, 2020년 4월 InnAccel Technologies는 코로나19 환자의 ICU 사용을 위한 비침습적 인공호흡기 시스템을 출시했습니다. 비침습적 인공호흡기 시스템 출시를 발표했습니다. 이 시스템은 저산소혈증이 악화된 환자를 치료하기 위해 인도에서 설계 및 제조되었습니다. 또한, 이 시스템은 지속적인 전기나 훈련된 호흡 치료사가 필요하지 않으며, 다양한 환경과 임상 응용 분야에서 작동할 수 있습니다.

WHO는 현재 COPD로 인한 사망의 약 90%가 중저소득 국가에서 발생하는 것으로 추정하고 있습니다. 따라서 이러한 질환의 유병률 증가, 신제품 출시, 호흡기 질환 치료를 위한 휴대용, 저비용, 사용하기 쉬운 기계식 인공호흡기의 가용성이 세계 시장 성장의 원동력이 될 것으로 예상됩니다. 예를 들어, 2020년 8월 Spicejet은 휴대용 비침습적 기계식 인공호흡기 Spiceoxy를 출시했습니다. 최종 사용자들 사이에서 인지도가 높아짐에 따라 예측 기간 동안 수요가 증가할 것으로 예상됩니다.

아시아태평양과 라틴아메리카는 예측 기간 동안 유리한 성장세를 보일 것으로 예상됩니다. 이러한 성장은 미개척 기회의 존재, 지출 수준 증가, 유리한 정부 이니셔티브의 도입에 기인합니다. 시장 진출기업들은 지속적으로 신제품을 개발하여 존재감을 높이고 지속가능성을 확보하기 위해 노력하고 있습니다. 예를 들어, 2021년 4월 Dragerwerk AG &Co.KGaA는 STIMIT AG의 과반수 지분을 인수했습니다. 이 인수를 통해 회사는 폐를 보호하는 기계식 인공호흡기 부문의 숙련도를 더욱 높이고 있습니다.

기계식 인공호흡기 시장 보고서 하이라이트

• 수송용 및 휴대용 기계식 인공호흡기는 예측 기간 동안 유리한 CAGR을 나타낼 것으로 예상됩니다. 병원은 환자가 도착하기 전에도 신속하고 지속적인 치료를 제공하기 위해 휴대용 인공호흡기 사용을 장려하고 있습니다. 휴대용 인공호흡기는 재택 치료를 받고자 하는 환자의 요구를 충족시키기 위해 점점 더 널리 보급되고 있습니다.
• 비침습적 환기 모드 부문은 2023년 가장 큰 매출 점유율을 차지하며 예측 기간 동안 가장 빠른 성장을 보일 것으로 예상됩니다. 비침습적 인공호흡은 환자를 효과적으로 지원하고 삽관이 필요하지 않기 때문에 이 부문의 성장을 뒷받침하고 있습니다.
• 재택치료의 최종 용도 부문은 예측 기간 동안 유리한 CAGR을 나타낼 것으로 예상됩니다. 재택치료는 고가의 입원에 대한 비용 효율적인 대안이기 때문에 향후 몇 년동안 인기가 높아질 것으로 예상됩니다.
• 2023년에는 북미가 시장을 독점할 것으로 예상되는데, 이는 미국의 노인 인구 증가와 이에 따른 호흡기 질환 발생이 증가하고 있기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 기계식 인공호흡기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 기계식 인공호흡기 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석
• COVID-19가 기계식 인공호흡기 시장에 미치는 영향
• 지역 레벨에서의 가격 분석
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 지역에서 시장 미충족 요구
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제4장 기계식 인공호흡기 시장 : 제품 유형, 추정·동향 분석

• 부문 대시보드
• 기계식 인공호흡기 시장 : 제품 유형 변동 분석, 100만 달러, 2023년과 2030년

제5장 기계식 인공호흡기 시장 : 환기 모드, 추정·동향 분석

• 부문 대시보드
• 기계식 인공호흡기 시장 : 환기 모드 변동 분석, 100만 달러, 2023년과 2030년

제6장 기계식 인공호흡기 시장 : 최종 용도, 추정·동향 분석

• 부문 대시보드
• 기계식 인공호흡기 시장 : 최종 용도 변동 분석, 100만 달러, 2023년과 2030년

제7장 기계식 인공호흡기 시장 : 지역 추정·동향 분석

• 지역별 시장 점유율 분석, 2023년과 2030년
• 지역 시장 대시보드
• 세계 지역 시장 현황
• 시장 규모, 예측 동향 분석, 2018-2030년 :
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 기업/경쟁 분류
• 기존 시장 진출기업 철퇴 전략과 경쟁사에 대한 영향
  • Koninklijke Philips NV(2024년 1월)
  • Medtronic(2024년 2월)
  • Teleflex Incorporated(2021년 6월)
• 벤더 구도
  • 주요 기업의 시장 점유율 분석, 2023년
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK
  • MicroPort Scientific Corporation
  • Koninklijke Philips NV
  • Stryker
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • NIHON KOHDEN CORPORATION
  • Schiller AG
  • ResMed
  • Fisher &Paykel Healthcare Limited
  • Dragerwerk AG &Co. KGaA
  • Getinge AB
  • ZOLL Medical Corporation(Asahi Kasei Corporation)
  • Air Liquide
  • VYAIRE MEDICAL, INC.
  • GE Healthcare
  • Hamilton Medical
  • Smiths Group plc
  • Allied Medical LLC(A Flexicare Company)
  • aXcent Medical GmbH
  • Metran Co., Ltd
  • MAGNAMED
  • Avasarala Technologies Limited
  • Airon Corporation
  • Bio-Med Devices
  • Hill-Rom(Baxter)
  • HEYER Medical AG
  • Leistung Engineering Pvt. Ltd.

LSH

영문 목차

영문목차

Mechanical Ventilator Market Growth & Trends:

The global mechanical ventilator market size is expected to reach USD 4.22 billion by 2030, registering a CAGR of 4.90% during the forecast period, according to a new report by Grand View Research, Inc. The unprecedented dawn of COVID19, increasing incidence of chronic obstructive pulmonary disease (COPD), rising incidence of respiratory emergencies, and technological innovation in respiratory care devices are the major factors driving the market for mechanical ventilators.

Technical advancements such as rapid innovation in the field of Positive Airway Pressure (PAP) devices, portability, and improvement in battery life of transport and portable devices are the primary factors that encourage the usage of mechanical ventilators. In April 2020, InnAccel Technologies announced the introduction of a non-invasive ventilation system intended for usage in ICU with COVID-19 patients. This system was engineered and manufactured in India to treat patients with deteriorating hypoxemia. Besides, this system functions across numerous settings and clinical applications, without the necessity of continuous electricity, or a trained breathing therapist.

The WHO estimates that at present, approximately 90% of COPD deaths occur in low- and middle-income countries. Therefore, the rise in the prevalence of such diseases, new product launches, and the availability of portable, cost-contained, and easy-to-use mechanical ventilators for the treatment of respiratory conditions are expected to fuel the market growth worldwide. For instance, in August 2020, Spicejet introduced Spiceoxy, a portable, non-invasive ventilation device. The increasing awareness amongst the end users is projected to boost the demand over the forecast period.

Asia Pacific and Latin America are expected to witness lucrative growth over the forecast period. This growth is due to the presence of untapped opportunities, rising expenditure levels, and the introduction of favorable government initiatives. Market participants are constantly engaged in the development of new products in an attempt to improve presence and ensure sustainability. For instance, in April 2021, Dragerwerk AG & Co. KGaA has acquired the majority share of STIMIT AG. With this purchase, the company further increases its proficiency in the lung-protective ventilation field.

Mechanical Ventilator Market Report Highlights:

• Transport and portable ventilators are expected to register a lucrative CAGR over the forecast period. Hospitals are promoting the use of portable breathing machines to provide faster and continuous care to patients even prior to their arrival on the premises. Portable breathing machines fulfill the need of patients to obtain home care, thereby increasing their popularity
• The non-invasive ventilation mode segment held the largest revenue share in 2023 and is expected to witness the fastest growth during the forecast period. Non-invasive ventilation effectively supports and prevents the necessity for intubation in patients, thus supporting the segment growth
• The home healthcare end-use segment is expected to register a lucrative CAGR over the forecast period. This is a cost-efficient alternative to expensive hospital stays, hence is anticipated to gain popularity in the coming years
• North America dominated the market in 2023 owing to the rising geriatric population in the U.S., which is leading to a corresponding rise in the incidences of respiratory disorders along with a manufacturing boost.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Type outlook
  • 2.2.2. Ventilator Mode Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Mechanical Ventilator Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence Of Respiratory Diseases
    • 3.2.1.2. Technological advancement
    • 3.2.1.3. Increasing Number Of Government Initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Capital Intensive Nature
    • 3.2.2.2. Product Recall And Failure
• 3.3. Mechanical Ventilator Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
• 3.4. Impact of COVID-19 on mechanical ventilator market
• 3.5. Pricing Analysis, at Regional Level
  • 3.5.1. North America
  • 3.5.2. Europe
  • 3.5.3. Asia Pacific
  • 3.5.4. Latin America
  • 3.5.5. MEA
• 3.6. Unmet Need in the Market, at Regional Level
  • 3.6.1. North America
  • 3.6.2. Europe
  • 3.6.3. Asia Pacific
  • 3.6.4. Latin America
  • 3.6.5. MEA

Chapter 4. Mechanical Ventilator Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Mechanical Ventilator Market: Product Type Movement Analysis, USD Million, 2023 & 2030
  • 4.2.1. Critical Care Ventilators
    • 4.2.1.1. Critical Care Ventilators Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 4.2.1.2. Ventilators
    • 4.2.1.2.1. Ventilators Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 4.2.1.3. Accessories
    • 4.2.1.3.1. Accessories Market Estimates And Forecasts, 2018 - 2030(USD Billion)
  • 4.2.2. Neonatal
    • 4.2.2.1. Neonatal Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 4.2.2.2. Ventilators
    • 4.2.2.2.1. Ventilators Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 4.2.2.3. Accessories
    • 4.2.2.3.1. Accessories Market Estimates And Forecasts, 2018 - 2030(USD Billion)
  • 4.2.3. Transport And Portable Ventilators
    • 4.2.3.1. Transport And Portable Ventilators Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 4.2.3.2. Ventilators
    • 4.2.3.2.1. Ventilators Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 4.2.3.3. Accessories
    • 4.2.3.3.1. Accessories Market Estimates And Forecasts, 2018 - 2030(USD Billion)
  • 4.2.4. Other Ventilators
    • 4.2.4.1. Other Ventilators Market Estimates And Forecasts, 2018 - 2030(USD Billion)

Chapter 5. Mechanical Ventilators Market: Ventilation Mode Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Mechanical Ventilator Market: Ventilation Mode Movement Analysis, USD Million, 2023 & 2030
  • 5.2.1. Invasive
    • 5.2.1.1. Invasive Market Estimates And Forecasts, 2018 - 2030(USD Billion)
  • 5.2.2. Non-Invasive
    • 5.2.2.1. Non-Invasive Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 5.2.2.2. Non-Invasive Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 5.2.2.3. Continuous Positive Airway Pressure (CPAP)
    • 5.2.2.3.1. CPAP Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 5.2.2.4. Bilevel Positive Airway Pressure (BPAP)
    • 5.2.2.4.1. BPAP Market Estimates And Forecasts, 2018 - 2030(USD Billion)
    • 5.2.2.5. Others
    • 5.2.2.5.1. Others Market Estimates And Forecasts, 2018 - 2030(USD Billion)

Chapter 6. Mechanical Ventilator Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Mechanical Ventilator Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 6.2.1. Hospitals
    • 6.2.1.1. Hospitals Market Estimates And Forecasts, 2018 - 2030(USD Billion)
  • 6.2.2. Home Healthcare
    • 6.2.2.1. Home Healthcare Market Estimates And Forecasts, 2018 - 2030(USD Billion)
  • 6.2.3. Others
    • 6.2.3.1. Others Market Estimates And Forecasts, 2018 - 2030(USD Billion)

Chapter 7. Mechanical Ventilator Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Exit Strategies of Existing Market Players And Their Impact On Market Competitors
  • 8.3.1. Koninklijke Philips N.V.(January, 2024)
  • 8.3.2. Medtronic (February, 2024)
  • 8.3.3. Teleflex Incorporated (June, 2021)
• 8.4. Vendor Landscape
  • 8.4.1. Key company market share analysis, 2023
  • 8.4.2. Medtronic
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Abbott
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Boston Scientific Corporation
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. BIOTRONIK
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. MicroPort Scientific Corporation
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Koninklijke Philips N.V.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Stryker
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. NIHON KOHDEN CORPORATION
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Schiller AG
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. ResMed
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Fisher & Paykel Healthcare Limited
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. Dragerwerk AG & Co. KGaA
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Product benchmarking
    • 8.4.14.4. Strategic initiatives
  • 8.4.15. Getinge AB
    • 8.4.15.1. Company overview
    • 8.4.15.2. Financial performance
    • 8.4.15.3. Product benchmarking
    • 8.4.15.4. Strategic initiatives
  • 8.4.16. ZOLL Medical Corporation (Asahi Kasei Corporation)
    • 8.4.16.1. Company overview
    • 8.4.16.2. Financial performance
    • 8.4.16.3. Product benchmarking
    • 8.4.16.4. Strategic initiatives
  • 8.4.17. Air Liquide
    • 8.4.17.1. Company overview
    • 8.4.17.2. Financial performance
    • 8.4.17.3. Product benchmarking
    • 8.4.17.4. Strategic initiatives
  • 8.4.18. VYAIRE MEDICAL, INC.
    • 8.4.18.1. Company overview
    • 8.4.18.2. Financial performance
    • 8.4.18.3. Product benchmarking
    • 8.4.18.4. Strategic initiatives
  • 8.4.19. GE Healthcare
    • 8.4.19.1. Company overview
    • 8.4.19.2. Financial performance
    • 8.4.19.3. Product benchmarking
    • 8.4.19.4. Strategic initiatives
  • 8.4.20. Hamilton Medical
    • 8.4.20.1. Company overview
    • 8.4.20.2. Financial performance
    • 8.4.20.3. Product benchmarking
    • 8.4.20.4. Strategic initiatives
  • 8.4.21. Smiths Group plc
    • 8.4.21.1. Company overview
    • 8.4.21.2. Financial performance
    • 8.4.21.3. Product benchmarking
    • 8.4.21.4. Strategic initiatives
  • 8.4.22. Allied Medical LLC (A Flexicare Company)
    • 8.4.22.1. Company overview
    • 8.4.22.2. Financial performance
    • 8.4.22.3. Product benchmarking
    • 8.4.22.4. Strategic initiatives
  • 8.4.23. aXcent Medical GmbH
    • 8.4.23.1. Company overview
    • 8.4.23.2. Financial performance
    • 8.4.23.3. Product benchmarking
    • 8.4.23.4. Strategic initiatives
  • 8.4.24. Metran Co., Ltd
    • 8.4.24.1. Company overview
    • 8.4.24.2. Financial performance
    • 8.4.24.3. Product benchmarking
    • 8.4.24.4. Strategic initiatives
  • 8.4.25. MAGNAMED
    • 8.4.25.1. Company overview
    • 8.4.25.2. Financial performance
    • 8.4.25.3. Product benchmarking
    • 8.4.25.4. Strategic initiatives
  • 8.4.26. Avasarala Technologies Limited
    • 8.4.26.1. Company overview
    • 8.4.26.2. Financial performance
    • 8.4.26.3. Product benchmarking
    • 8.4.26.4. Strategic initiatives
  • 8.4.27. Airon Corporation
    • 8.4.27.1. Company overview
    • 8.4.27.2. Financial performance
    • 8.4.27.3. Product benchmarking
    • 8.4.27.4. Strategic initiatives
  • 8.4.28. Bio-Med Devices
    • 8.4.28.1. Company overview
    • 8.4.28.2. Financial performance
    • 8.4.28.3. Product benchmarking
    • 8.4.28.4. Strategic initiatives
  • 8.4.29. Hill-Rom (Baxter)
    • 8.4.29.1. Company overview
    • 8.4.29.2. Financial performance
    • 8.4.29.3. Product benchmarking
    • 8.4.29.4. Strategic initiatives
  • 8.4.30. HEYER Medical AG
    • 8.4.30.1. Company overview
    • 8.4.30.2. Financial performance
    • 8.4.30.3. Product benchmarking
    • 8.4.30.4. Strategic initiatives
  • 8.4.31. Leistung Engineering Pvt. Ltd.
    • 8.4.31.1. Company overview
    • 8.4.31.2. Financial performance
    • 8.4.31.3. Product benchmarking
    • 8.4.31.4. Strategic initiatives

관련자료